# Evaluation of the GORE® ACUSEAL Vascular Graft for Hemodialysis Access

Study · id `cardio:ct-nct01173718` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01173718](<https://clinicaltrials.gov/study/NCT01173718>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01173718

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 138 participants.

## Technical summary

Registry record NCT01173718. Allocation not applicable; no masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2012-09 (actual). Results posted on 2013-07-02.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 138 participants (enrolled count; ClinicalTrials.gov record NCT01173718, source copy `cardio:ctgov-nct01173718-2013-07-26`, retrieved 2026-10-26)
- Start date: 2010-07 (registry gives no type) (ClinicalTrials.gov record NCT01173718, source copy `cardio:ctgov-nct01173718-2013-07-26`, retrieved 2026-10-26)
- Primary completion: 2012-09 (actual) (ClinicalTrials.gov record NCT01173718, source copy `cardio:ctgov-nct01173718-2013-07-26`, retrieved 2026-10-26)
- Completion: 2013-02 (actual) (ClinicalTrials.gov record NCT01173718, source copy `cardio:ctgov-nct01173718-2013-07-26`, retrieved 2026-10-26)
- Results first posted: 2013-07-02 (ClinicalTrials.gov record NCT01173718, source copy `cardio:ctgov-nct01173718-2013-07-26`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01173718-2013-07-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of the GORE® ACUSEAL Vascular Graft for Hemodialysis Access
- Acronym: ACUSEAL
- Condition: End Stage Renal Disease
- Intervention (Device): GORE® ACUSEAL Vascular Graft
- Lead sponsor: W.L.Gore & Associates
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: W.L.Gore & Associates (`cardio:org-w-l-gore-associates`)

## Provenance

Content hash: 8b04173d555150b03fbe5c9d2ca802ddb106715e1d99601ee9b56e2b5db773e0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
